A guide for functional analysis ofBRCA1variants of uncertain significance
- 2 July 2012
- journal article
- review article
- Published by Hindawi Limited in Human Mutation
- Vol. 33 (11), 1526-1537
- https://doi.org/10.1002/humu.22150
Abstract
Germline mutations in the tumor suppressor gene BRCA1 confer an estimated lifetime risk of 56–80% for breast cancer and 15–60% for ovarian cancer. Since the mid 1990s when BRCA1 was identified, genetic testing has revealed over 1,500 unique germline variants. However, for a significant number of these variants, the effect on protein function is unknown making it difficult to infer the consequences on risks of breast and ovarian cancers. Thus, many individuals undergoing genetic testing for BRCA1 mutations receive test results reporting a variant of uncertain clinical significance (VUS), leading to issues in risk assessment, counseling, and preventive care. Here, we describe functional assays for BRCA1 to directly or indirectly assess the impact of a variant on protein conformation or function and how these results can be used to complement genetic data to classify a VUS as to its clinical significance. Importantly, these methods may provide a framework for genome‐wide pathogenicity assignment. Hum Mutat 33:1526–1537, 2012.Keywords
This publication has 134 references indexed in Scilit:
- Classification of missense substitutions in the BRCA genes: A database dedicated to Ex-UVsHuman Mutation, 2011
- ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesHuman Mutation, 2011
- A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)Human Mutation, 2011
- Assessment of human nter and cterBRCA1mutations using growth and localization assays in yeastHuman Mutation, 2011
- Down‐regulation of BRCA1 expression by miR‐146a and miR‐146b‐5p in triple negative sporadic breast cancersEMBO Molecular Medicine, 2011
- Detection of splicing aberrations caused by BRCA1 and BRCA2 sequence variants encoding missense substitutions: implications for prediction of pathogenicityHuman Mutation, 2010
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- Mouse embryonic stem cell–based functional assay to evaluate mutations in BRCA2Nature Medicine, 2008
- Functional assays for BRCA1 and BRCA2The International Journal of Biochemistry & Cell Biology, 2007
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995